Pfizer Inc (PFE.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
As of 08:10AM CEST. Market open.
| Previous close | 25.93 |
| Open | 25.97 |
| Bid | 26.03 x 0 |
| Ask | 26.07 x 0 |
| Day's range | 25.97 - 25.97 |
| 52-week range | 23.64 - 37.35 |
| Volume | |
| Avg. volume | 551 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Zacks
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
- Zacks
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
© 2024 Yahoo. All rights reserved.